Screener
Tyra Biosciences, Inc. TYRA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 50,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 59,469,687 and 53,706,357 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 6 | 5 |
| Additional paid-in capital | 798,025 | 630,037 |
| Accumulated other comprehensive income | 107 | 393 |
| Accumulated deficit | (410,563) | (371,258) |
| Total stockholders’ equity | 387,575 | 259,177 |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s common stock?
- Tyra Biosciences, Inc. (TYRA) reported common stock of $6K in Q1 2026.
- How has Tyra Biosciences, Inc.'s common stock changed year-over-year?
- Tyra Biosciences, Inc.'s common stock increased by 20.0% year-over-year, from $5K to $6K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Tyra Biosciences, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude